Arbutus Announces Late-Breaker Abstract Accepted for Present

WARMINSTER, Pa., Nov. 01, 2021 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused…

Related Keywords

Canada , Toronto , Ontario , Canadian , Lisam Caperelli , Williamh Collier , , Arbutus Biopharma Corporation Nasdaq , Postmedia Network Inc , Securities Exchange , Arbutus Announces Late Breaker Abstract Accepted , Liver Meeting , Arbutus Biopharma Corporation , American Association , Liver Diseases , Digital Experience , Presentation Details , Late Breaking Abstract , Session Schedule , Biopharma Corporation , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports , Investor Relations , Postmedia Network , Street East ,